NAPG mutation in family members with hereditary hemorrhagic telangiectasia in China

BMC Pulm Med. 2021 Jun 10;21(1):197. doi: 10.1186/s12890-021-01524-4.

Abstract

Background: Hereditary hemorrhagic telangiectasia (HHT) is a disease characterized by arteriovenous malformations in the skin and mucous membranes. We enrolled a large pedigree comprising 32 living members, and screened for mutations responsible for HHT.

Methods: We performed whole-exome sequencing to identify novel mutations in the pedigree after excluding three previously reported HHT-related genes using Sanger sequencing. We then performed in silico functional analysis of candidate mutations that were obtained using a variant filtering strategy to identify mutations responsible for HHT.

Results: After screening the HHT-related genes, activin A receptor-like type 1 (ACVRL1), endoglin (ENG), and SMAD family member 4 (SMAD4), we did not detect any co-segregated mutations in this pedigree. Whole-exome sequencing analysis of 7 members and Sanger sequencing analysis of 16 additional members identified a mutation (c.784A > G) in the NSF attachment protein gamma (NAPG) gene that co-segregated with the disease. Functional prediction showed that the mutation was deleterious and might change the conformational stability of the NAPG protein.

Conclusions: NAPG c.784A > G may potentially lead to HHT. These results expand the current understanding of the genetic contributions to HHT pathogenesis.

Keywords: Hereditary hemorrhagic telangiectasia; NAPG; Whole-exome sequencing.

MeSH terms

  • China
  • Exome Sequencing
  • Family*
  • Female
  • Humans
  • Male
  • Mutation
  • Pedigree
  • Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins / genetics*
  • Telangiectasia, Hereditary Hemorrhagic / genetics*

Substances

  • NAPG protein, human
  • Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins